Mavragani CP - Search Results

1

Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjögren's syndrome.

Blokland SLM, Flessa CM, van Roon JAG, Mavragani CP. Blokland SLM, et al. Among authors: mavragani cp. Rheumatology (Oxford). 2021 Jul 1;60(7):3072-3087. doi: 10.1093/rheumatology/key438. Rheumatology (Oxford). 2021. PMID: 30838419

2

Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides.

Karaiskos D, Mavragani CP, Sinno MH, Déchelotte P, Zintzaras E, Skopouli FN, Fetissov SO, Moutsopoulos HM. Karaiskos D, et al. Among authors: mavragani cp. Rheumatology (Oxford). 2010 Sep;49(9):1762-9. doi: 10.1093/rheumatology/keq158. Epub 2010 Jun 4. Rheumatology (Oxford). 2010. PMID: 20525741

3

Type I interferonopathy in a young adult.

Manoussakis MN, Mavragani CP, Nezos A, Zampeli E, Germenis A, Moutsopoulos HM. Manoussakis MN, et al. Among authors: mavragani cp. Rheumatology (Oxford). 2017 Dec 1;56(12):2241-2243. doi: 10.1093/rheumatology/kex316. Rheumatology (Oxford). 2017. PMID: 28968819 No abstract available.

4

Primary versus Secondary Sjögren Syndrome: Is It Time To Reconsider These Terms?

Mavragani CP, Moutsopoulos HM. Mavragani CP, et al. J Rheumatol. 2019 Jul;46(7):665-666. doi: 10.3899/jrheum.180392. J Rheumatol. 2019. PMID: 31262751 No abstract available.

5

Type I interferon signature in Sjögren's syndrome: pathophysiological and clinical implications.

Marketos N, Cinoku I, Rapti A, Mavragani CP. Marketos N, et al. Among authors: mavragani cp. Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):185-191. Epub 2019 Jul 11. Clin Exp Rheumatol. 2019. PMID: 31376268 Free article. Review.

6

Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome.

Flessa CM, Vlachiotis S, Nezos A, Andreakos E, Mavragani CP, Tektonidou MG. Flessa CM, et al. Among authors: mavragani cp. Clin Immunol. 2019 Dec;209:108265. doi: 10.1016/j.clim.2019.108265. Epub 2019 Oct 19. Clin Immunol. 2019. PMID: 31639447

7

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome.

Flessa CM, Zampeli E, Evangelopoulos ME, Natsis V, Bodewes ILA, Huijser E, Versnel MA, Moutsopoulos HM, Mavragani CP. Flessa CM, et al. Among authors: mavragani cp. Front Immunol. 2022 Mar 15;13:836824. doi: 10.3389/fimmu.2022.836824. eCollection 2022. Front Immunol. 2022. PMID: 35371038 Free PMC article.

8

Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.

Kintrilis N, Gravani F, Rapti A, Papaioannou M, Flessa CM, Nezos A, Antypa E, Papadaki I, Karageorgas Τ, Moutsopoulos HM, Mavragani CP. Kintrilis N, et al. Among authors: mavragani cp. Rheumatology (Oxford). 2023 Feb 1;62(2):958-968. doi: 10.1093/rheumatology/keac337. Rheumatology (Oxford). 2023. PMID: 35689637

9

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations.

Mavragani CP, Kirou KA, Seshan SV, Crow MK. Mavragani CP, et al. Rheumatology (Oxford). 2023 Jul 5;62(7):2534-2538. doi: 10.1093/rheumatology/keac641. Rheumatology (Oxford). 2023. PMID: 36355567 Free PMC article.

10

Recurrent pregnancy loss and autoantibody profile in autoimmune diseases.

Mavragani CP, Ioannidis JP, Tzioufas AG, Hantoumi IE, Moutsopoulos HM. Mavragani CP, et al. Rheumatology (Oxford). 1999 Dec;38(12):1228-33. doi: 10.1093/rheumatology/38.12.1228. Rheumatology (Oxford). 1999. PMID: 10587550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters